Captopril enhances cardiac vagal but not sympathetic neurotransmission in pithed rats

Journal of Pharmacological Sciences

Volumn 95, Issue 3, 2004, Pages 390-393

  Takata, Yoshinobu ^a   Arai, Takanori ^a   Suzuki, Shigeto ^a   Kurihara, Junichi ^a   Uezono, Takashi ^a   Okubo, Yoko ^a   Kato, Hitoshi ^a  

^a Teikyo University   (Japan)

Author keywords

Autonomic neurotransmission; Captopril; Rat heart

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; BRADYKININ; CAPTOPRIL;

ACETYLCHOLINE RELEASE; ADRENERGIC TRANSMISSION; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART INNERVATION; MALE; NERVE STIMULATION; NEUROTRANSMISSION; NONHUMAN; PRESYNAPTIC INHIBITION; RAT; SPINAL ANIMAL; SPINAL RAT; SYMPATHETIC NERVE; TACHYCARDIA; VAGUS NERVE;

EID: 3843140406     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.SCJ04003X     Document Type: Article

References (15)

1. Johnston CI, Arnold AL, Hiwatari M. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs. 1984;27:271-277.
2. Kondowe GB, Deering AH, Riddell JG, Johnston GD, Harron DWG. The effect of acute and chronic captopril therapy on baroreflex function in man. Br J Clin Pharmacol. 1988;25:315-321.
3. Kurihara J, Yoda T, Suzuki S, Takata Y, Kato H. Effects of angiotensin AT1 receptor antagonists on the sympathetic neurotransmission in rat hearts. Jpn J Pharmacol. 1999;79 Suppl I:184P.
4. 1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats. J Cardiovasc Pharmacol. 2001;37:427-436.
5. Eckberg DL. Parasympathetic cardiovascular control in human disease: a critical review of methods and results. Am J Physiol. 1980;239:H581-H593.
6. Hosono M, Fujii S, Hiruma T, Watanabe K, Hayashi Y, Ohnishi H, et al. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol. 1995;69:127-134.
7. Dendorfer A, Hauser W, Falias D, Dominiak P. Bradykinin increases catecholamine release via B2 receptors. Pflugers Arch. 1996;432:R99-R106.
8. Campbell BC, Sturani A, Reid JL. Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci. 1985;68:49-56.
9. Potter EK. Peripheral inhibition of the parasympathetic nervous system by angiotensin. Clin Exp Pharmacol Physiol. 1982;1 Suppl 7:51-55.
10. Chubb IW, Hodgson AJ, White GH. Acetylcholinesterase hydrolyzes substance P. Neuroscience. 1980;5:2065-2072.
11. Antonaccio MJ, Kerwin L. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR: implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril. Hypertension. 1981;3 Suppl I:I-54-I-62.
12. Hatton R, Clough DP. Captopril interferes with neurogenic vasoconstriction in the pithed rat by angiotensin-dependent mechanisms. J Cardiovasc Pharmacol. 1982;4:116-123.
13. Kaufman LJ, Vollmer RR. Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats. J Pharmacol Exp Ther. 1985;235:128-134.
14. Grant TL, McGrath JC. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rats. Br J Pharmacol. 1988;95:1220-1228.
15. De Jonge A, Knape JThA, Van Meel JCA, Kalkman HO, Wilffert B, Thoolen MJMC, et al. Effect of captopril on sympathetic neurotransmission in pithed normotensive rats. Eur J Pharmacol. 1983;88:231-240.